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besity Stresses
ardiac Mitochondria
ven When You Are Young*
. Dale Abel, MBBS, DPHIL
alt Lake City, Utah
besity is an independent risk factor for the development of
eart failure. Although the mechanisms are multifactorial
nd include increased coronary atherosclerosis and ischemic
eart disease, increased hypertension, and obstructive sleep
pnea, there is growing evidence that intrinsic defects
ithin cardiomyocytes might contribute to the increased
ulnerability of the heart in these subjects (1) (Fig. 1).
See page 577
echanistic Studies Linking
besity With Cardiac Dysfunction
nimal models. The majority of studies that have at-
empted to elucidate potential mechanisms for myocardial
ysfunction in obesity have been performed in animal
odels. Moreover, given the close association between
besity, insulin resistance, and type 2 diabetes, it has not
lways been straightforward to distinguish between those
hanges that can truly be attributable to obesity and those
hat are secondary to systemic metabolic changes caused by
nsulin resistance or impaired glucose tolerance. Neverthe-
ess, evidence suggests that obesity and insulin resistance
ight be associated with a number of pathophysiological
onsequences intrinsic to the cardiomyocyte that may im-
air left ventricular (LV) function. These include changes in
yocardial substrate utilization (increased fatty acid uptake
nd oxidation and decreased glucose utilization), mitochon-
rial dysfunction (decreased oxidative phosphorylation and
itochondrial uncoupling), oxidative stress, increased apo-
tosis, the accumulation of toxic lipid intermediates (lipo-
oxicity), altered myocardial insulin action, and altered
yocardial calcium handling (2).
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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elationships to disclose.uman studies. Fewer studies exist in humans, but those
hat have been performed in subjects with obesity, insulin
esistance, or type 2 diabetes have provided evidence for
imilar changes in myocardial substrate utilization, de-
reased cardiac efficiency, increased myocardial lipid accu-
ulation, and in some studies, reduced concentrations of
yocardial high-energy phosphates (creatine phosphate/
denosine triphosphate ratios), which might indicate mito-
hondrial dysfunction (3,4).
itochondrial Dysfunction in Human Heart Samples
atients with diabetes. The role of mitochondrial dys-
unction has attracted increased interest in recent studies in
nimals and humans and has been the subject of a number
f reviews (2,5). There are intrinsic challenges in studying
itochondrial function in human heart samples because of
imited tissue availability. However, some groups have
egun to analyze human right atrial materials that are
btained at the time of coronary artery bypass grafting. A
ecent study of subjects with type 2 diabetes revealed clear
vidence for mitochondrial dysfunction and increased oxi-
ative stress in permeabilized right atrial cardiac fibers (6).
owever, these patients had relatively poorly controlled
iabetes in addition to obesity, and as such, it is not possible
o determine the relative contributions of hyperglycemia and
besity to the mitochondrial dysfunction.
bese or older individuals. In this issue of the Journal,
iemann et al. (7) report a study of right atrial cardiomy-
cytes from a large cohort of subjects with preserved LV
unction who underwent coronary artery bypass grafting.
ubjects were stratified by age and body mass index (BMI)
nto young (age 55 years) or old (age 70 years) and lean
BMI 25 kg/m2) or obese (BMI 30 kg/m2). Subjects
ith diabetes were excluded. The major findings of this
tudy were that young subjects with obesity exhibited
vidence of mitochondrial dysfunction, oxidative stress,
itochondrial oxidative damage, and activation of apopto-
is, to levels that were similar to those observed in older
ubjects with or without obesity. The investigators also
howed in an animal model of obesity (Zucker diabetic fatty
ats) that patterns of altered expression of genes that encode
itochondrial proteins and markers of apoptosis were sim-
lar in atria and ventricles. Thus, this study suggests that
besity per se might be sufficient to impair mitochondrial
unction in the heart and provides a novel mechanism,
howing for the first time in human samples that mitochon-
rial dysfunction could potentially contribute to the in-
reased susceptibility of the myocardium of obese individ-
als to heart failure. It should be noted, however, that many
f the changes observed in the young obese subjects were
lso seen in old normal-weight subjects, and the interaction
f age and obesity did not have a synergistic impact on these
arameters, nor did the older obese subjects exhibit worse
V function. Thus, it remains to be established if the
itochondrial dysfunction that is observed in young and
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isk for heart failure.
echanisms for Myocardial
itochondrial Dysfunction in Obesity
he role of altered systemic metabolism. The obvious
uestion that these intriguing results raise is that of the
echanism(s) that might be responsible for the changes
bserved. In this regard, a number of possibilities warrant
iscussion (Fig. 2). First, although the investigators ex-
luded subjects with diabetes, it is clear that all of the
ubjects with mitochondrial dysfunction (i.e., young obese
ubjects and older subjects irrespective of BMI) exhibited
mpaired fasting glucose concentrations. Moreover, the
verage glycosylated hemoglobin of old and young obese
ubjects was 5.7%, which according to new diagnostic
uidelines for diabetes would place these subjects at in-
reased risk for developing diabetes and cardiovascular
isease (8). Thus, the possibility remains that relatively
inor changes in glucose homeostasis might be sufficient to
mpair mitochondrial function and promote oxidative stress.
t is also likely (on the basis of earlier studies) that these
ubjects with impaired glucose tolerance and insulin resis-
ance may exhibit altered myocardial substrate utilization,
hich is characterized by increased myocardial fatty acid
tilization (9) and increased myocardial triglyceride accu-
ulation (10), both of which could independently contrib-
te to mitochondrial dysfunction and oxidative stress
Extrinsic
Volume expansion
Increased Cardiac output
Hypertension 
Sleep disordered breathing
Sympathetic activation
Activation of the renin angio-
tensin system
Increased vascular tone
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Increased triglycerides
Increased FFA
Hypoadiponectinemia
Hyperlipidemia
Increased coronary atherosclerosis
Ischemic heart disease
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Figure 1 Mechanisms Contributing to Cardiac Dysfunction in O
(Left) Factors that are extrinsic to the heart, such as coronary disease and athero
metabolic abnormalities that could influence cardiac function in obesity. (Right) C
could potentially impair cardiac function. FA  fatty acid; FFA  free fatty acid; NOIntrinsic
Altered substrate metabolism
- Increased FA oxidation
- Decreased glucose utilization
- Reduced cardiac efficiency
Oxidative stress
Mitochondrial dysfunction
Apoptosis
Lipotoxicity
Altered Ca2+ dynamics
Inflammation
Fibrosis
Cardiac Dysfunction in Obesity
besity
sclerosis, vascular dysfunction, altered hemodynamic parameters, or neurohumoral or
hanges that develop within cardiomyocytes (intrinsic) in the context of obesity that
 nitric oxide.11,12).Glucose
FFA
Insulin
LV Hypertrophy
LV DysfunctionAdiponectin
Extrinsic and Intrinsic Mechanisms Contributing to 
Myocardial Mitochondrial Dysfunction in Obesity
Transcription of nuclear-encoded 
mitochondrial genes
Transcription of mitochondrial-encoded genes
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?
Figure 2 Schematic Representation of Potential Mechanisms
That May Impair Mitochondrial Function in Obesity
Increased substrate availability such as increased glucose or free fatty acids
(FFAs) could impair mitochondrial function via mechanisms such as promoting
oxidative stress or post-translational modifications of mitochondrial proteins.
Insulin resistance and hyperinsulinemia might increase fatty acid (FA) uptake,
and decreased adiponectin signaling might reduce mitochondrial biogenesis.
Left ventricular (LV) hypertrophy and LV dysfunction are independently associ-
ated with reduced mitochondrial function. Intracellular mechanisms that could
lead to impaired mitochondrial function in obesity are summarized. PGC  per-
oxisome proliferator–activated receptor-gamma coactivator; ROS  reactive oxy-
gen species.
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Obesity and Cardiac Mitochondria February 1, 2011:586–9he potential contribution of cardiac hypertrophy or left
entricular dysfunction. Blood pressure was significantly
ncreased in young obese subjects and in older subjects and
racked with increased circulating concentrations of
-terminal pro–brain natriuretic peptide. This therefore
aises the possibility that subtle degrees of LV dysfunction
r LV hypertrophy could be present in the obese and older
ubjects. There is a significant literature, mainly in animal
odels, indicating that pressure-overload cardiac hypertro-
hy is associated with reduced mitochondrial function in the
eart (13). Most of the data on energetics in human hearts
ave focused on subjects with heart failure, in which there is
clear evidence of reduced myocardial energetics (14).
herefore, the present study leaves open the possibility that
ore subtle degrees of contractile dysfunction might be
ufficient to lead to impaired mitochondrial function in the
uman heart. Of course, it must be borne in mind that
amples were obtained from the right atrium, not from the
eft ventricle. As such, it would have been helpful for the
nvestigators to provide information on left atrial size and to
etermine myocyte diameter in the atria to determine if
ardiomyocyte hypertrophy was present. An increase in
ight atrial size could also occur if there is mild pulmonary
ypertension. Obesity increases the risk for sleep apnea,
hich may increase pulmonary vascular resistance, so future
tudies should examine the relationship between pulmonary
ressures, atrial size, and mitochondrial function in similar
ohorts of subjects. Finally, it is possible that increased
xpression of atrial natriuretic peptide in the heart could be
econdary to the insulin resistance and diabetes, given
nimal studies illustrating this relationship (15).
olecular Mechanisms for
itochondrial Dysfunction in Obese Humans
ranscriptional signaling. The present study also raises
nteresting questions about potential molecular mechanisms
or the mitochondrial dysfunction that was observed in
bese subjects. The investigators observed reduced expres-
ion of nuclear respiratory factor-1 and its transcriptional
arget, Tfam, which might account for reduced expression
f the mitochondrially encoded complex I protein ND6.
essenger ribonucleic acid levels of the nuclear-encoded
DUFB8 were also reduced, but interestingly, this occurred
n the absence of any changes in the expression of peroxi-
ome proliferator–activated receptor-gamma coactivator
-alpha (PGC-1). Studies in rodent models have consis-
ently revealed an association between pathological cardiac
ypertrophy and reduced PGC-1 expression (16). How-
ver, recent studies in failing human hearts suggest that
efective mitochondrial function in heart failure may occur
ndependently of changes in PGC-1 and are more strongly
ssociated with defective replication of mitochondrial de-
xyribonucleic acid and reduced signaling via the PGC-1
artner estrogen-related receptor– (17). Therefore, this
tudy supports the general notion that in the human heart,
Uathophysiological impairment of mitochondrial function
ay occur independently of changes in PGC-1.
ormonal signaling. Circulating adiponectin concentra-
ions as well as cardiomyocyte expression of adiponectin
ere reduced in atrial cardiomyocytes isolated from young
bese subjects and old subjects, irrespective of obesity.
ecent work has suggested that adiponectin may play an
mportant role in signaling to mitochondrial biogenesis via
Sirt1-mediated deacetylation of PGC-1 (18), thus im-
licating decreased adiponectin signaling as a potential
ediator of the mitochondrial dysfunction that was ob-
erved. Finally, impaired insulin signaling has been shown
o contribute to mitochondrial dysfunction in the heart (19).
lthough the subjects in this study were clearly insulin
esistant, the status of insulin signaling in their hearts was
ot ascertained. A recent study examining LV biopsy
aterials from subjects with type 2 diabetes suggested that
lthough insulin-mediated glucose uptake was impaired in
he heart, proximal insulin signaling via insulin receptor
ubstrate 1 to phosphoinositide 3-kinase was increased (20).
oreover, we recently reported in animal studies that
xcessive insulin signaling could accelerate adverse LV
emodeling, although the impact on mitochondrial function
n this context is not yet understood (21).
onclusions
he study by Niemann et al. (7) demonstrates an association
etween obesity and mitochondrial dysfunction in the heart.
lthough it is not possible to determine from these results
he mechanisms for this association, or if the mitochondrial
ysfunction was secondary to obesity or to subtle hemody-
amic or systemic metabolic abnormalities, they do provide
ovel insight into early mitochondrial abnormalities that
xist before significant changes in cardiac function. The
ndings suggest that these defects in mitochondrial func-
ion, oxidative stress, and increased apoptosis could be the
arbinger of progressive LV dysfunction or of increased
ulnerability to a subsequent insult, such as myocardial
schemia. This latter scenario is more plausible given that
rogressive LV dysfunction was not observed in older and
bese subjects who were studied before an inciting event
uch as a myocardial infarction. To address this important
uestion, it will be necessary to develop robust noninvasive
urrogate measures of cardiac mitochondrial function that
ill enable prospective analyses of the long-term impact of
besity-associated mitochondrial dysfunction on clinically
ignificant cardiovascular end points such as incident heart
ailure and cardiovascular mortality.
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